Roche Holding AG (RHHBY)
32.76
-0.05
(-0.15%)
USD |
OTCM |
May 20, 14:46
Roche Accounts Receivable (Quarterly): 13.85B for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 13.85B |
June 30, 2023 | 12.33B |
June 30, 2023 | 12.33B |
December 31, 2022 | 13.08B |
June 30, 2022 | 11.33B |
June 30, 2022 | 11.33B |
December 31, 2021 | 12.50B |
June 30, 2021 | 12.66B |
June 30, 2021 | 12.66B |
December 31, 2020 | 12.03B |
June 30, 2020 | 12.27B |
June 30, 2020 | 12.27B |
December 31, 2019 | 11.16B |
June 30, 2019 | 12.04B |
June 30, 2019 | 12.04B |
December 31, 2018 | 10.28B |
June 30, 2018 | 10.46B |
June 30, 2018 | 10.46B |
December 31, 2017 | 10.12B |
June 30, 2017 | 9.627B |
June 30, 2017 | 9.627B |
December 31, 2016 | 8.725B |
June 30, 2016 | 9.292B |
June 30, 2016 | 9.292B |
December 31, 2015 | 8.543B |
Date | Value |
---|---|
June 30, 2015 | 8.772B |
June 30, 2015 | 8.772B |
December 31, 2014 | 9.207B |
June 30, 2014 | 9.608B |
June 30, 2014 | 9.608B |
December 31, 2013 | 9.996B |
June 30, 2013 | 10.17B |
June 30, 2013 | 10.17B |
December 31, 2012 | 10.53B |
June 30, 2012 | 9.902B |
June 30, 2012 | 9.902B |
December 31, 2011 | 10.46B |
June 30, 2011 | 10.63B |
June 30, 2011 | 10.63B |
December 31, 2010 | 9.975B |
June 30, 2010 | 9.661B |
December 31, 2009 | 9.914B |
June 30, 2009 | 9.673B |
December 31, 2008 | 9.015B |
June 30, 2008 | 9.352B |
June 30, 2008 | 9.352B |
December 31, 2007 | 8.534B |
June 30, 2007 | 7.907B |
June 30, 2007 | 7.907B |
December 31, 2006 | 7.343B |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
11.16B
Minimum
Dec 2019
13.85B
Maximum
Dec 2023
12.26B
Average
12.27B
Median
Jun 2020
Accounts Receivable (Quarterly) Benchmarks
Novartis AG | 7.84B |
Pfizer Inc | 10.99B |
ADC Therapeutics SA | 23.19M |
Lonza Group Ltd | 1.355B |
Sarepta Therapeutics Inc | 378.81M |